Personalized Brain Stimulation: A Breakthrough in Parkinson’s Treatment

Adaptive deep brain stimulation tailored to each patient's symptoms cuts debilitating episodes by half, as shown in a new UCSF study published in Nature Medicine.

The Human Story Behind the Science

Shawn Connolly was diagnosed with Parkinson’s disease at 39, and soon his skateboarding skills began to fade. Involuntary hand movements and balance issues made everyday life difficult. Traditional treatments offered limited help, so he volunteered for a groundbreaking study on adaptive deep brain stimulation (aDBS). The result? His most debilitating symptoms were cut in half, giving him longer periods of feeling normal. Connolly now runs a skateboard program for kids, a legacy built with his late wife, Thuy Nguyen.

How Adaptive DBS Works

Published in Nature Medicine, the study led by researchers at the University of California, San Francisco (UCSF) introduces a personalized aDBS system. Unlike conventional DBS, which delivers constant stimulation, this system uses a real-time algorithm that adjusts electrical pulses based on each patient’s brain signals. It specifically targets signals linked to stiffness (bradykinesia) and uncontrolled movements (dyskinesia). The result is fewer and less severe symptoms, significantly improving quality of life.

Real‑World Impact

Past studies were limited to lab settings, but this one allowed participants to live normally—skateboarding, traveling, exercising. Wearable monitors tracked movements and daily questionnaires measured outcomes. The data showed a clear reduction in symptom burden. Connolly could even tell when adaptive stimulation was active versus conventional, feeling sluggish with the latter.

Beyond Parkinson’s

The success of personalized DBS opens doors for other neurological and psychiatric conditions. Early experiments show promise for depression, obsessive‑compulsive disorder (OCD), and chronic pain. As Dr. Jaimie Henderson of Stanford University notes, personalized stimulation is likely the future of neurological treatments. Advances in AI and wearable tech make it possible to refine algorithms continuously as patients’ conditions evolve.

Challenges Ahead

Developing personalized algorithms remains time‑consuming. The first patient required two years to devise an effective algorithm, but by the fourth patient that time dropped to two weeks. Frequent adjustments are needed as symptoms and medications change. Accessibility and cost are also hurdles; widespread adoption will require making the technology more affordable. Researchers and healthcare providers must collaborate on scalable solutions.

What’s Next?

With ongoing research and AI improvements, brain pacemakers tailored to individual needs could become standard within a decade. The time to develop personalized plans will likely shrink further. For millions of patients worldwide, this adaptive approach offers new hope—not just for managing symptoms, but for living fuller, more active lives.